NCT01009177View on ClinicalTrials.gov

Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Melanoma
Interventions
DRUG

Bosentan

Bosentan 500 mg bid

DRUG

Placebo

Placebo

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY